He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
Karol E. Watson, MD, PhD, Professor of Medicine/Cardiology, Co-director, UCLA Program in Preventative Cardiology; Director, UCLA Barbra Streisand Women's Heart Health Program, is a Cardiologist who worked...
Bruce Given, MD explains how alpha-1 antitrypsin deficiency (AATD) is most often associated with pulmonary disease in adults and liver disease in children. However, as treatment of adults with AATD has...
In his last video, Garret Duron, MD, explained which questions rheumatologists can ask themselves when determining whether a piece of COVID-19 literature will be helpful to them. But what information would...
